MindImmune Therapeutics agrees to acquire two programs from H. Lundbeck

MINDIMMUNE THERAPEUTICS has entered into an agreement with Lundbeck tow acquire two programs related to neuropathic pain and Huntington's disease. / COURTESY MINDIMMUNE THERAPEUTICS
MINDIMMUNE THERAPEUTICS has entered into an agreement with Lundbeck tow acquire two programs related to neuropathic pain and Huntington's disease. / COURTESY MINDIMMUNE THERAPEUTICS
SOUTH KINGSTOWN –MindImmune Therapeutics Inc. has entered into agreements with H. Lundbeck A/S to acquire programs and will develop candidates from these programs as novel…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

- Advertisement -